跳至主要内容
临床试验/EUCTR2013-002955-13-IT
EUCTR2013-002955-13-IT进行中(未招募)不适用

Effects of Vildaglipin and Glimepiride on Glycemic Variability and on Cardiovascular parameters in patients with type 2 diabetes in failure with basal insulin

AFAR0 个研究点开始时间: 2013年9月30日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
AFAR

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - age between 40 and 80 years
  • - Both sexes
  • - Treated with metformin and basal insulin
  • - With HbA1c between 7-9%
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 48
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • - Type 1 diabetes;
  • - Chronic systemic diseases, immunologic, neoplastic;
  • - Cardiovascular, renal and hepatic
  • - AST, ALT 2 times higher than the reference values
  • - Women who are pregnant or intend to become pregnant
  • - Breastfeeding women.
  • - Drug therapy can interfere with glucose metabolism

研究者

发起方
AFAR

相似试验